Literature DB >> 23972017

Short communication: Evidence that microbial translocation occurs in HIV-infected children in the United Kingdom.

Felicity Fitzgerald1, Kathryn Harris, Ronan Doyle, Dagmar Alber, Nigel Klein.   

Abstract

Microbial translocation (MT) from the gut is implicated in driving immune activation, increasing morbidity and mortality in HIV. We used bacterial 16S rDNA PCR, Sanger sequencing, and high-throughput sequencing to identify microbial DNA in the bloodstream of HIV-infected children in London, United Kingdom. Blood samples were collected from sequential children attending the HIV clinic at Great Ormond Street Hospital, London. DNA extraction, broad range 16S rDNA PCR, and standard Sanger sequencing were carried out. A subset of positive samples was analyzed by high-throughput sequencing (Roche 454 platform). Of 105 samples collected from sequential children, nine were positive using broad range 16S rDNA PCR (8.6%; 95% CI 4.4-16%). From three amplicons, 16S rDNA sequences were identified as Streptococcus, Propionibacterium acnes, and coagulase-negative Staphylococcus. Four positive samples were analyzed by high-throughput sequencing. In the three samples in which organisms were identified by Sanger sequencing, the same species were identified. Further species, in differing proportions, were identified in all four samples. The identified organisms included known gut orders Bifidobacteriaceae, Lactobacillaceae, Bacteroidales, and Clostridiales. In immunocompetent children of equivalent age, no bacterial DNA was detected in blood using this approach. This is the first study to our knowledge using molecular techniques to identify MT in children in the developed world. Our data indicate that 16S rDNA is detectable in 8.6% of HIV-infected children. Levels of DNA were low and from multiple bacterial species. Further studies are needed to ascertain the importance of MT in HIV-infected children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23972017      PMCID: PMC3848482          DOI: 10.1089/AID.2013.0097

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  50 in total

Review 1.  Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology.

Authors:  B Cherie Millar; Jiru Xu; John E Moore
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 2.  Unresolved antiretroviral treatment management issues in HIV-infected children.

Authors:  Shirin Heidari; Lynne M Mofenson; Charlotte V Hobbs; Mark F Cotton; Richard Marlink; Elly Katabira
Journal:  J Acquir Immune Defic Syndr       Date:  2012-02-01       Impact factor: 3.731

3.  Plasma levels of bacterial DNA in HIV infection: the limits of quantitative polymerase chain reaction.

Authors:  Emanuele Ferri; Stefano Novati; Maurizio Casiraghi; Vittorio Sambri; Francesca Genco; Roberto Gulminetti; Claudio Bandi
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

Review 4.  The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.

Authors:  Lidia Gazzola; Camilla Tincati; Giusi Maria Bellistrì; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

5.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

6.  Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.

Authors:  Sudheesh Pilakka-Kanthikeel; Sharon Huang; Terry Fenton; William Borkowsky; Coleen K Cunningham; Savita Pahwa
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

Review 7.  Microbial translocation across the GI tract.

Authors:  Jason M Brenchley; Daniel C Douek
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

8.  Unique case of Helicobacter sp. osteomyelitis in an immunocompetent child diagnosed by broad-range 16S PCR.

Authors:  Kathryn A Harris; Katy J Fidler; John C Hartley; Julie Vogt; Nigel J Klein; Fergal Monsell; Vas M Novelli
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.

Authors:  Nicholas T Funderburg; Elizabeth Mayne; Scott F Sieg; Robert Asaad; Wei Jiang; Magdalena Kalinowska; Angel A Luciano; Wendy Stevens; Benigno Rodriguez; Jason M Brenchley; Daniel C Douek; Michael M Lederman
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

View more
  8 in total

1.  Stability of the gorilla microbiome despite simian immunodeficiency virus infection.

Authors:  Andrew H Moeller; Martine Peeters; Ahidjo Ayouba; Eitel Mpoudi Ngole; Amadine Esteban; Beatrice H Hahn; Howard Ochman
Journal:  Mol Ecol       Date:  2015-01-19       Impact factor: 6.185

2.  Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting.

Authors:  Sudheesh Pilakka-Kanthikeel; Arheart Kris; Anbalagan Selvaraj; Soumya Swaminathan; Savita Pahwa
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

Review 3.  Gut Microbiota in HIV Infection: Implication for Disease Progression and Management.

Authors:  Felix Chinweije Nwosu; Ekaterina Avershina; Robert Wilson; Knut Rudi
Journal:  Gastroenterol Res Pract       Date:  2014-06-12       Impact factor: 2.260

4.  Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents.

Authors:  Patricia Alvarez; Mussa Mwamzuka; Fatma Marshed; Adam Kravietz; Tiina Ilmet; Aabid Ahmed; William Borkowsky; Alka Khaitan
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

5.  Evaluation of the effect of HIV virus on the digestive flora of infected versus non infected infants.

Authors:  Celine Nguefeu Nkenfou; William Baiye Abange; Hortense Kamga Gonsu; Nelly Kamgaing; Emilia Mbamyah Lyonga; Jean de Dieu Anoubissi; Alexis Ndjolo; Paul Koki
Journal:  Pan Afr Med J       Date:  2019-09-11

6.  Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.

Authors:  Maximilian Muenchhoff; Michael Healy; Ravesh Singh; Julia Roider; Andreas Groll; Chirjeev Kindra; Thobekile Sibaya; Angeline Moonsamy; Callum McGregor; Michelle Q Phan; Alejandro Palma; Henrik Kloverpris; Alasdair Leslie; Raziya Bobat; Philip LaRussa; Thumbi Ndung'u; Philip Goulder; Magdalena E Sobieszczyk; Mohendran Archary
Journal:  AIDS Res Hum Retroviruses       Date:  2017-09-06       Impact factor: 2.205

7.  Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV.

Authors:  Felicity C Fitzgerald; Edouard Lhomme; Kathryn Harris; Julia Kenny; Ronan Doyle; Cissy Kityo; Liam P Shaw; George Abongomera; Victor Musiime; Adrian Cook; Julianne R Brown; Anthony Brooks; Ellen Owen-Powell; Diana M Gibb; Andrew J Prendergast; A Sarah Walker; Rodolphe Thiebaut; Nigel Klein
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

8.  The immunological and virological consequences of planned treatment interruptions in children with HIV infection.

Authors:  Nigel Klein; Delali Sefe; Ilaria Mosconi; Marisa Zanchetta; Hannah Castro; Marianne Jacobsen; Hannah Jones; Stefania Bernardi; Deenan Pillay; Carlo Giaquinto; A Sarah Walker; Diana M Gibb; Anita De Rossi
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.